S. Mishina

Improvement in prescriptions while maintaining overall health outcomes: a prospective observational study conducted in Japanese facilities for older people

S. Ikeda, A. Igarashi, Yoshimasa Takase, 2022, BMC Geriatrics.

Assessing the Budget Impact and Economic Outcomes of the Introduction of Daclatasvir + Asunaprevir and Sofosbuvir/Ledipasvir for the Treatment of Chronic Hepatitis C Virus Infection in Japan.

P. McEwan, T. Ward, G. Wygant, 2017, Value in health regional issues.

Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.

S. Morita, T. Hirano, S. Mishina, 2017, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Systemic Treatment Patterns With Advanced or Recurrent Non-small Cell Lung Cancer in Japan: A Retrospective Hospital Administrative Database Study.

Y. Ohe, S. Matsuoka, S. Mishina, 2017, Clinical therapeutics.

A retrospective database analysis of erythropoiesis‐stimulating agent treatment patterns and associated healthcare resource use in patients with non–dialysis‐dependent chronic kidney disease–related anaemia in Japan

Y. Yasuda, Yuichiro Ito, S. Mishina, 2023, Nephrology.

Re-challenge of Platinum-based Chemotherapy for Platinum-refractory Patients with Recurrent or Metastatic Head and Neck Cancer: Claims Data Analysis in Japan

M. Tahara, T. Murata, S. Mishina, 2020, Journal of health economics and outcomes research.